IMPROVING THE LIVES OF INDIVIDUALS AND FAMILIES FACING HEREDITARY CANCER.

Use our Search and Enroll Tool to find research studies enrolling people like you.
June 22, 2022
What Chris Evert’s Story Can Teach the World about Genetic Testing
by Ellen T. Matloff, MS, CGC; CEO, My Gene Counsel Tennis champion Chris Evert generously shared her family’s genetic testing story with the world last year, as Angelina Jolie did almost a decade before. Like Jolie’s story, Evert’s has the...

Featured XRAY
Breast cancer risk for transgender men with inherited mutations
There is little information related to the risks and treatment options for transgender men and nonbinary people who are at high-risk for breast cancer due to an inherited BRCA1 or BRCA2 mutation. We review an...
Featured Research
PARP inhibitor (niraparib) in patients with inherited or tumor PALB2 mutations in advanced solid tumors (PAVO)
PAVO is an open-label Phase II study investigating if the study drug, a PARP inhibitor called niraparib (Zejula), is safe and effective for certain people who have been diagnosed with an advanced solid tumor with...
Meet Our Community
Our impact is best shared through the stories of our growing community. Read about the survivors and previvors facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers as a result of a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those with Lynch syndrome. We are comprised of many mutations and many cancers but we are one community!

Be Empowered Webinar Series
Our live and on demand webinars feature presentations by experts on topics of interest and importance to our community.